EOS designs orthopedic medical imaging and software solutions. Credit: Harlie Raethel /Unsplash.

Medical device company Alphatec Holdings (ATEC) has signed an agreement to acquire Paris-based EOS imaging.

The deal, a combination of cash and equity, includes a purchase price of up to $88m and debt retirement of $33.9m.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

EOS designs orthopaedic medical imaging and software solutions. The company is known for its low dose, biplanar full-body imaging and 3D modelling capabilities.

EOS’ product portfolio includes spineEOS, an online 3D planning software for spine surgery approved by US Food and Drug Administration (FDA).

ATEC chairman and CEO Pat Miles said: “This is a monumental transaction for ATEC. While spine’s large players are investing in enabling technologies, we are thinking differently. We created a conduit to deliver information into the operating room with AlphaInformatiX.

“This transaction will integrate spine imaging and anatomical modelling onto the platform to actually inform the operative experience. By pairing ATEC’s approach-based solutions with imaging founded on Nobel Prize-winning technology, we expect to significantly increase demand for ATEC hardware and EOS systems and create a formidable competitive advantage.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

With the addition of EOS imaging, ATEC’s AlphaInformatiX platform’s delivering capabilities will boost in patient-specific implants, surgical planning, intraoperative alignment reconciliation, and other intraoperative functionalities.

The transaction is expected to be accretive to ATEC’s revenue growth, as well as create cross-selling opportunities due to the expanded customer base and sales network.

Under the agreement, EOS’s shareholders will receive approximately $3.08 per EOS share under the cash offer or 0.50 ATEC common shares per the EOS share under the exchange offer.